Discontinued — last reported Q2 '22
Natera, Inc. Short-Term Borrowings decreased by 0.0% to $80.31M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.0%, from $80.35M to $80.31M. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows an upward trend with a 9.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $50.05M | $50.05M | $50.05M | $50.06M | $50.09M | $50.15M | $80.35M | $80.40M | $80.42M | $80.44M | $80.40M | $80.40M | $80.39M | $80.47M | $80.36M | $80.35M | $80.34M | $80.34M | $80.32M | $80.31M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.1% | +0.1% | +60.2% | +0.1% | +0.0% | +0.0% | -0.0% | -0.0% | -0.0% | +0.1% | -0.1% | -0.0% | -0.0% | +0.0% | -0.0% | -0.0% |
| YoY Change | — | — | — | — | +0.1% | +0.2% | +60.5% | +60.6% | +60.6% | +60.4% | +0.1% | +0.0% | -0.0% | +0.0% | -0.0% | -0.1% | -0.1% | -0.2% | -0.0% | -0.0% |